Market Access Why ‘reduce, reuse, and recycle' medicine is the future The ultimate raison d’être of any medicine is to benefit patients.
Patients UK-wide whole genome sequencing for newborns is feasible - b... Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year ann
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
